SLC6A3 and drug-induced dyskinesia: Furthermore, a recent study demonstrated that the initially low posterior putaminal DAT activity is closely coupled not only with dyskinesia development but also with the timing of levodopa-induced dyskinesia onset in patients with de novo PD [141].